In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis
Authors:
- Lisa R. ReynoldsLRLisa R. Reynolds
- Steven C. BudsbergSBSteven C. Budsberg
- 1 May 2005
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 66 (5) , 812-817
Abstract
Objective —To evaluate in vivo activity of carprofen, deracoxib, and etodolac on prostanoid production in several target tissues in dogs with chronic osteoarthritis. Animals —8 dogs with chronic unilateral osteoarthritis of the stifle joint. Procedure —Each dog received carprofen, deracoxib, or etodolac for 10 days with a 30- to 60-day washout period between treatments. On days 0, 3, and 10, prostaglandin (PG) E 2 concentrations were measured in lipopolysaccharide-stimulated blood, synovial fluid, and gastric mucosal biopsy specimens; PGE 1 concentrations were measured in gastric mucosal biopsy specimens; and thromboxane B 2 (TXB 2 ) was evaluated in blood. Results —Carprofen and deracoxib significantly suppressed PGE 2 concentrations in blood at days 3 and 10, compared with baseline, whereas etodolac did not. None of the drugs significantly suppressed TXB 2 concentrations in blood or gastric PGE 1 synthesis at any time point. All 3 drugs significantly decreased gastric synthesis of PGE 2 at day 3 but not day 10 of each treatment period. All 3 drugs decreased synovial fluid PGE 2 concentrations in the affected and unaffected stifle joints at days 3 and 10. Conclusions and Clinical Relevance —Results indicate that carprofen and deracoxib act in vivo on target tissues as COX-1–sparing drugs by sparing gastric PGE 1 and PGE 2 synthesis and production of TXB 2 by platelets. Etodolac also appears to be COX-1 sparing but may have variable effects on COX-2 depending on the tissue. In gastric mucosa and synovial fluid, there were no significant differences in PG production between compounds at recommended concentrations. ( Am J Vet Res 2005;66:812–817)Keywords
This publication has 25 references indexed in Scilit:
- Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugsAmerican Journal of Veterinary Research, 2004
- In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogsAmerican Journal of Veterinary Research, 2002
- Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine bloodAmerican Journal of Veterinary Research, 2002
- In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and catsAmerican Journal of Veterinary Research, 2001
- The Coxibs, Selective Inhibitors of Cyclooxygenase-2New England Journal of Medicine, 2001
- Long-term temporal evaluation of ground reaction forces during development of experimentally induced osteoarthritis in dogsAmerican Journal of Veterinary Research, 2001
- Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and catsJournal of the American Veterinary Medical Association, 2000
- In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogsAmerican Journal of Veterinary Research, 2000
- Anti-inflammatory drugs and their mechanism of actionInflammation Research, 1998
- Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugsInflammation Research, 1998